Stockscreener 앱 받기
1.81
2.69%
-0.05
전일 마감가:
$1.86
열려 있는:
$1.83
하루 거래량:
3.34M
Relative Volume:
0.89
시가총액:
$294.99M
수익:
-
순이익/손실:
$-111.13M
주가수익비율:
-1.3712
EPS:
-1.32
순현금흐름:
$-91.53M
1주 성능:
-13.81%
1개월 성능:
+48.36%
6개월 성능:
+302.22%
1년 성능:
-15.81%
1일 변동 폭
$1.77
$1.86
1주일 범위
$1.77
$2.20
52주 변동 폭
$0.36
$4.01
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
명칭
Tenaya Therapeutics Inc
전화
415-865-2066
주소
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
TNYA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
1.81 | 303.14M | 0 | -111.13M | -91.53M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-10 | 개시 | William Blair | Outperform |
| 2023-11-30 | 개시 | Leerink Partners | Outperform |
| 2022-06-15 | 개시 | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc 주식(TNYA)의 최신 뉴스
Why Tenaya Therapeutics Inc. stock appeals to analystsRecession Risk & Verified Swing Trading Watchlists - Trung tâm Dự báo KTTV quốc gia
Statistical indicators supporting Tenaya Therapeutics Inc.’s strengthMarket Performance Recap & Smart Money Movement Alerts - newser.com
Why Tenaya Therapeutics Inc. stock is a must watch in 2025July 2025 Snapshot & Verified Entry Point Signals - Trung tâm Dự báo KTTV quốc gia
What to expect from Tenaya Therapeutics Inc. in the next 30 daysBreakout Watch & Precise Swing Trade Entry Alerts - newser.com
Does Tenaya Therapeutics Inc. qualify in momentum factor screeningWeekly Investment Recap & Stock Timing and Entry Methods - newser.com
Should you wait for a breakout in Tenaya Therapeutics Inc.2025 Buyback Activity & Expert Approved Trade Ideas - newser.com
Does Tenaya Therapeutics Inc. show high probability of rebound2025 Earnings Surprises & High Return Stock Watch Alerts - newser.com
Is Tenaya Therapeutics Inc. still worth holding after the dipWeekly Profit Analysis & Stepwise Entry and Exit Trade Signals - newser.com
Will Tenaya Therapeutics Inc. stock continue dividend increases2025 EndofYear Setup & Technical Pattern Based Signals - newser.com
Momentum divergence signals in Tenaya Therapeutics Inc. chartM&A Rumor & AI Based Trade Execution Alerts - newser.com
Applying chart zones and confluence areas to Tenaya Therapeutics Inc.Weekly Trade Recap & AI Based Buy/Sell Signal Reports - newser.com
Intraday pattern recognizer results for Tenaya Therapeutics Inc.July 2025 Outlook & Short-Term Trading Alerts - newser.com
What Fibonacci levels say about Tenaya Therapeutics Inc. reboundJuly 2025 PostEarnings & Risk Controlled Stock Pick Alerts - newser.com
What analysts say about Tenaya Therapeutics Inc stockEarnings Call Summaries & Affordable Growth Trading - earlytimes.in
Tenaya Therapeutics (TNYA): Evaluating Valuation After Investor Buzz on MyPEAK-1 and RIDGE-1 Clinical Updates - Yahoo Finance
Real time scanner hits for Tenaya Therapeutics Inc. explainedEarnings Trend Report & Verified Entry Point Signals - newser.com
Tenaya Therapeutics Stock (TNYA) Opinions on CEO Conference Appearances - Quiver Quantitative
When Will Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Become Profitable? - 富途牛牛
Tenaya Therapeutics (NASDAQ:TNYA) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
Tenaya Therapeutics to Participate in H.C. Wainwright Genetic Medicines Virtual Conference - The Manila Times
Fireside chat Oct 14: Tenaya Therapeutics CEO Faraz Ali at H.C. Wainwright; 1x1 meetings Oct 15, replay 30 days - Stock Titan
Can Tenaya Therapeutics’ Leadership Messaging Shape Long-Term Perceptions and Value Creation for TNYA? - Yahoo Finance
Using RSI to spot recovery in Tenaya Therapeutics Inc.Earnings Beat & Accurate Technical Buy Alerts - newser.com
How Might Tenaya Therapeutics' (TNYA) Industry Visibility Influence Its Strategic Positioning? - Sahm
Is now a turning point for Tenaya Therapeutics Inc.July 2025 Update & Trade Opportunity Analysis - newser.com
Does Tenaya Therapeutics Inc. fit your quant trading model2025 Support & Resistance & High Conviction Buy Zone Picks - newser.com
What recovery options are there for Tenaya Therapeutics Inc.Trade Signal Summary & Expert Approved Momentum Trade Ideas - newser.com
Tenaya Therapeutics CEO Faraz Ali to Speak at Upcoming Investor and Industry Conferences in October 2025 - Quiver Quantitative
Tenaya Therapeutics to Participate in Upcoming October Investor Conferences - The Manila Times
Oct 6 & Oct 21: Tenaya Therapeutics CEO Faraz Ali to Present at Investor Conferences — Webcast Archived 30 Days - Stock Titan
Tenaya Therapeutics Inc (TNYA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.84%
0.50%
자본화:
|
볼륨(24시간):